欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/V/0237/001
药品名称Bovilis IBR marker inac
活性成分
    • bovine herpesvirus 2.0 ml
剂型Solution for injection
上市许可持有人Intervet Deutschland GmbH Postfach 1130 85701 Unterschleissheim Germany
参考成员国 - 产品名称Germany (DE)
Bovilis IBR Marker inac
互认成员国 - 产品名称
    • Belgium (BE)
      Bovilis IBR marker inac
    • Netherlands (NL)
      Bovilis IBR marker inac
    • Luxembourg (LU)
      Bovilis IBR marker inac
    • United Kingdom (Northern Ireland) (XI)
      Bovilis IBR marker inac
    • Ireland (IE)
      Bovilis IBR marker inac
    • France (FR)
      12370 - Bovilis IBR marker inac
    • Spain (ES)
      Bovilis IBR marker inac
    • Portugal (PT)
      Bovilis IBR marker inac
    • Italy (IT)
      Bovilis IBR marker inac
    • Greece (GR)
      Bovilis IBR marker inac
    • Poland (PL)
      Bovilis IBR marker inac
    • Latvia (LV)
      Bovilis IBR marker inac
    • Lithuania (LT)
      Bovilis IBR marker inac, injekcinis tirpalas galvijams
    • Estonia (EE)
      Bovilis IBR marker inac
    • Hungary (HU)
      Bovilis IBR marker inac
    • Czechia (CZ)
      Bovilis IBR marker inac
    • Slovakia (SK)
      Bovilis IBR marker inac
许可日期2006/07/05
最近更新日期2023/10/17
药物ATC编码
    • QI02AA03 bovine rhinotracheitis virus (IBR)
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:Full dossier Art 12.3 (j) Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase